Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Sellas Life Sciences Group is a biopharmaceutical company developing novel cancer immunotherapies and targeted treatments. Its core focus includes peptide-based vaccines and small molecule inhibitors targeting cancers such as AML, solid tumors, and lymphomas. The company’s products aim to activate the immune system against tumor-specific antigens, leveraging proprietary technology and strategic licensing to address unmet medical needs in oncology markets worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.